Framework for the Provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies
East Midlands Pharmacy CollaborativecontractContracts Finder ↗Ref CF-3015500D0O000000rwimUAASME suitablecomplete
Estimated value
—
Awarded value
£2.8m
Awarded 29 Apr 2025
Suppliers
1
Lots
1
1 awarded
Published
07 May 2025
Deadline 11 Oct 2024
Description
This Framework agreement is for the provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies initially for patients of East Midlands Pharmacy Collaborative (EMPC) Member Trusts referred to henceforth as the 'Service' to Participating Purchasing Authorities
Scope
- Reference
- CF-3015500D0O000000rwimUAA
- Commercial tool
- Standalone contract
- Contract dates
- 30 Apr 2025 to 29 Apr 2027
- CPV classifications
- 85100000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 11 Oct 2024, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£2.8m
Award date
29 Apr 2025
Contract start
30 Apr 2025
Contract end
29 Apr 2027